IP Library Granted Patent US 7,812,220
Granted Patent B2
US 7,812,220 · App. 12/289,255 · Granted Oct 12, 2010

Engineering β-ketoacyl ACP synthase for novel substrate specificity

Assignee: Calgene LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,812,220
App. No.
12/289,255
Granted
Oct 12, 2010
Kind
B2
Abstract

Methods of altering substrate specificity of beta-ketoacyl-ACP synthase, and engineered beta-ketoacyl-ACP synthases so produced are provided. DNA sequences and constructs for expression of engineered beta-ketoacyl-ACP synthases, as well as the novel beta-ketoacyl-ACP synthases produced therefrom are also provided. Such DNA sequences may be used for expression of the engineered beta-ketoacyl-ACP synthases in host cells, particularly seed cells of oilseed crop plants, for the modification of fatty acid composition.

Claims (17)

1. A method for altering the fatty acid composition of a plant seed comprising:

a) expressing in a transgenic plant an engineered β-Ketoacyl-acyl carrier protein synthase II, wherein the amino acid sequence of said engineered β-Ketoacyl-acyl carrier protein synthase II has an amino acid substitution in the hydrophobic pocket; and

b) harvesting a transgenic seed from said transgenic plant, wherein said harvested transgenic seed comprises an altered fatty acid composition compared to a plant seed not expressing said engineered β-Ketoacyl-acyl carrier protein synthase II wherein said altered fatty acid composition comprises an increase in long chain fatty acids.

2. The method of claim 1 , wherein said altered fatty acid composition is increased about 2- to 4-fold in the amount of long chain fatty acids compared to the amount of long chain fatty acids produced by a plant seed not expressing said engineered β-Ketoacyl-acyl carrier protein synthase II.

3. The method of claim 1 , wherein the amino acid sequence of said engineered β-Ketoacyl-acyl carrier protein synthase II has an amino acid substitution at a position corresponding to hydrophobic pocket residues selected from the group consisting of residues corresponding to amino acid positions 105-120, 130-140, 190-200, 340-345, and 400 of SEQ ID NO: 47, and said amino acid substitution results in lengthening of the hydrophobic pocket of said engineered β-Ketoacyl-acyl carrier protein synthase II.

4. The method of claim 3 , wherein said amino acid substitution is at an amino acid position selected from the group consisting of residues corresponding to amino acid positions I108, L111, I114, F133, and L197 of SEQ ID NO: 47.

5. The method of claim 4 , wherein said amino acid substitution is substituted with a hydrophobic amino acid.

6. The method of claim 5 , wherein said hydrophobic amino acid is alanine.

7. The method of claim 3 , wherein said amino acid substitution is a hydrophobic amino acid and results in an altered fatty acid composition with longer carbon chain lengths due to the addition of one or more two-carbon units.

8. The method of claim 7 , wherein said hydrophobic amino acid is alanine.

9. The method of claim 3 , wherein said amino acid substitutions are at amino acid positions corresponding to amino acid positions I108 and A193 of SEQ ID NO: 47.

10. The method of claim 9 , wherein said amino acid is substituted with a hydrophobic amino acid.

11. The method of claim 10 , wherein said amino acid is substituted with phenylalanine or leucine and isoleucine or methionine, respectively.

12. The method of claim 3 , wherein said amino acid substitution is at an amino acid position corresponding to amino acid position A193, I108, L342, V134 or F202 of SEQ ID NO: 47.

13. The method of claim 12 , wherein said amino acid is substituted with a hydrophobic amino acid.

14. The method of claim 13 , wherein said amino acid is substituted with glycine, glycine, alanine or glycine, alanine or glycine, or leucine, isoleucine or glycine, respectively.

15. The method of claim 1 , wherein said engineered β-Ketoacyl-acyl carrier protein synthase II is engineered E. coli β-KAS II.

Assignments (3)
MERGER Recorded Dec 1, 2010
From: MONSANTO AG PRODUCTS LLC
To: MONSANTO COMPANY
Reel/Frame 025416/0012 →
MERGER Recorded Nov 19, 2010
From: CALGENE LLC
To: MONSANTO AG PRODUCTS LLC
Reel/Frame 025376/0588 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2010
From: DEHESH, KATAYOON; VAL, DALE
To: CALGENE LLC
Reel/Frame 024870/0086 →
Continuity (4)
Continuation 1085189400 · May 24, 2004
Division 0959127900 · Jun 9, 2000
Provisional Application 6013830800 · Jun 9, 1999
Related Publication 20090075249A1 · Mar 19, 2009